• Reprocell: A Pioneer in Genomics Enhancing the Success Rate of Drug Discovery
  • Cover Story

    Reprocell: A Pioneer in Genomics Enhancing the Success Rate of Drug Discovery

    Indian pharmaceutical companies have moved up the evolution cycle to discover new drugs from merely producing them tremendous credit to the advent of Patents Act. Renowned for having the World’s second highest number of USFDA-approved plants, scientific workforce with an innovative spirit and economical R&D costs, India has the potential to lead the pack with its high end research services. While inventing new medicines is inspiring & exhilarating, it’s also an expensive & risky business that moves at a snail pace.

Company of the month
Content

Adding Value to the Healthcare Chain

Anamika Sahu, Managing Editor

Genomics & Future of Oncology in India

Dr. BS Ajaikumar, CEO, HealthCare Global Enterprises

Scientific & Technological (Ai Based) Advancement In Pharmaceutical R&D & Clinical Trials

Ravi Sekhar Kasibhatta, Senior Vice President, Lupin Bioresearch Center

Artificial Intelligence in Healthcare - Should We Let The Genie Out of the Bottle?

Prof. (Dr.) Mahipal S. Sachdev, Chairman, Medical Director & Senior Consultant - Ophthalmology, Centre for Sight

Pharma Captive Centres Moving up the Value Chain

Furhan Ahmed, Director - IT, Science & Enabling Units, AstraZeneca

Psycho-Oncology: Unlocking the Possibilities of the Mind

Suresh Ramu, Co-Founder & CEO, Cytecare Cancer Hospital

Contribution of Agri Biotech science in Gherkin Industry - India

Prabuddh Mishra, Founder & CEO, Vanproz Agrovet